It is a pharma private limited company based in Secunderabad, Telangana, India, established in 1989.
1989 | Secunderabad, Telangana, India | ActiveRichmond Biosciences Private Limited, a active private limited company, was established on 16 February 1989 in Secunderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24110TG1989PTC009623. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.98 M.
Formerly known as Vadlamani Intermediates And Chemicals Private Limited. It upholds a compliant status. Its leadership includes Sudhir Kumar Srivastava (Director), Tripti Srivastava (Director). Past directors included Raghuraman Dandapani, Nachhattar Singh Toor, Ayyagari Ramabhima Subrahmanya Sarma. It holds ₹1.89 Cr open charges and ₹0.45 M settled loans. Its latest AGM occurred on 29 September 2022, with the balance sheet filed on 31 March 2022. It is based at 'D' Block, 7Th Floor Queen'S Plaza, 100, S.P.Road, Secunderabad, Telangana, 500003.
U24110TG1989PTC009623
009623
16 February 1989
₹5.00 M
₹3.98 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Richmond Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudhir Kumar Srivastava | Director | 26 Jun 2015 | Current |
| Tripti Srivastava | Director | 02 Mar 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Jun 2015 | Past |
| Pramod Abcsdd | Director | 26 Jun 2015 | Past |
| Pramod Abcsdd | Director | 08 Oct 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Richmond Biosciences Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.41% increase in profit. The company's net worth dipped by a decrease of 3.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Richmond Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹18,865,000.00
₹450,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2007 | State Bank Of India | ₹1.50 Cr | Open |
| 06 May 1998 | State Bank Of India | ₹1.03 M | Open |
| 30 Apr 1991 | A.P.S.F.C | ₹0.32 M | Open |
| 15 Apr 1991 | State Bank Of India | ₹0.45 M | Open |
| 23 Jul 1990 | A.P.S.F.C. | ₹2.07 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Richmond Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Richmond Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Richmond Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Richmond Biosciences Private Limited last Annual general meeting of members was held on 29 Sep 2022 as per latest MCA records. was documented.
The activity Richmond Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was completed.
Progress on Sudhir Kumar Srivastava was appointed as a Director was appointed as a Director on 26 Jun 2015 & has been associated with this company since 10 years 6 months . was documented.
A charge with State Bank Of India of Rs. 15.00 M registered on 26 Jul 2007 with Charge ID 10063710 was modified on 29 Mar 2012. was recorded as a recent event.
A charge with State Bank Of India amounted to Rs. 15.00 M with Charge ID 10063710 was registered on 26 Jul 2007. was recorded as a recent event.
Progress on Tripti Srivastava was appointed as a Director was appointed as a Director on 02 Mar 2007 & has been associated with this company since 18 years 10 months . was documented.
The CIN of Richmond Biosciences Private Limited is U24110TG1989PTC009623.
Richmond Biosciences Private Limited is headquartered at 'D' Block, 7Th Floor Queen'S Plaza, 100, S.P.Road, Secunderabad, Telangana, 500003.
Richmond Biosciences Private Limited was incorporated on 16 February 1989.
The current directors of Richmond Biosciences Private Limited are
The primary industry of Richmond Biosciences Private Limited is Manufacturing.
Richmond Biosciences Private Limited is unlisted.
The authorized capital of Richmond Biosciences Private Limited is ₹5.00 M, and the paid-up capital is ₹3.98 M.
The compliance status of Richmond Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX